Elevate Medical Affairs Podcast Channel Leveraging AI for Medical Affairs
Nov 14, 2023
Sonal Bhatia, Chief Medical Officer for rare disease at Pfizer, shares her insights on the groundbreaking role of AI in medical affairs. She discusses how AI tools are revolutionizing clinical practices and transforming patient outcomes by enhancing diagnostic accuracy and streamlining workflows. The conversation delves into AI's potential in drug development and clinical trials, highlighting its ability to identify rare disease patients and improve collaboration across medical teams. Get ready for an enlightening exploration of AI's future in healthcare!
AI Snips
Chapters
Transcript
Episode notes
Document AI Processes
- Track what you're trying to solve with AI and how you're doing it.
- Documenting these processes helps validate results and gain FDA acceptance.
Faster Insights, Better Trials
- AI can process field insights quickly, unlike traditional methods that took weeks or months.
- This speed enables faster clinical trials and more relevant results for patients, physicians, and regulators.
Cross-Functional Insights
- AI helps combine insights from different silos (commercial, regulatory, clinical) that would normally remain separate.
- Combining these diverse insights can reveal unmet needs and spark new research ideas.